Erin L St. Onge

Erin L St. Onge, Pharm.D.

Assistant Dean For The Orlando Campus; Clinical Associate Professor

Department: Orlando Campus
Business Phone: (407) 313-7004
Business Email: estonge@ufl.edu

About Erin L St. Onge

Erin St. Onge, Pharm.D., joined the faculty in July 2002 to help start the University of Florida College of Pharmacy program in Orlando. As the assistant dean for the Orlando campus, she devotes her time to her various roles as teacher, advisor and administrator.

St. Onge graduated from the University of Florida College of Pharmacy with her Doctor of Pharmacy degree with honors in 1999. Upon graduation, she completed a residency in Community Clinical Pharmacy with St. Louis College of Pharmacy/Walgreens. Dr. St. Onge accepted her first faculty position with Texas Tech University School of Pharmacy at their Lubbock campus. During her two years with Texas Tech, she gained valuable experience with their 3-campus (Amarillo, Lubbock, Dallas) distance education program. Also, she developed a community site for 3rd and 4th year students, as well as a residency program in Community Clinical Pharmacy. Dr. St. Onge and her family moved to Orlando in summer of 2002 at which time she accepted the position as Campus Director for Orlando. Dr. St. Onge has practiced ambulatory care in a variety of settings. She currently holds a joint appointment with the University of Central Florida College of Medicine where she provides clinical pharmacy services to patients at UCF Health. Additionally, Dr. St. Onge is very involved with interprofessional education initiatives with several schools/colleges within the University of Central Florida (Medicine, Nursing, Social Work, Physical Therapy, etc). The group was recently awarded the inaugural IPEC/USPHS National Award for Excellence in Interprofessional Education for their efforts at a student/faculty run clinic in Apopka, Florida. In addition to her current position with UF College of Pharmacy, she is very active in national pharmacy organizations and has held numerous leadership positions in state and local pharmacy organizations. Dr. St. Onge’s interests include diabetes mellitus, cardiovascular disease, and women’s health.

Research Profile

Research Interests: Diabetes Mellitus, Cardiovascular Disease

Publications

2021
Diabetes: Pharmacotherapy for Type 2 Diabetes.
FP essentials. 504:22-27 [PMID] 33970588.
View on: PubMed
2021
Diabetes: Type 1 Diabetes.
FP essentials. 504:11-15 [PMID] 33970586.
View on: PubMed
2021
Minocycline Topical Foam: A New Drug for the Treatment of Acne.
The Annals of pharmacotherapy. 55(1):105-110 [DOI] 10.1177/1060028020939926. [PMID] 32618475.
2021
Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson’s Disease.
The Annals of pharmacotherapy. 55(9):1159-1166 [DOI] 10.1177/1060028020974560. [PMID] 33233916.
2021
Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis
Journal of Pharmacy Technology. 37(1):45-52 [DOI] 10.1177/8755122520967632.
2011
Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus.
Expert opinion on biological therapy. 11(11):1525-32 [DOI] 10.1517/14712598.2011.610789. [PMID] 21913874.
2011
Redesign of a Pediatric Pharmacotherapy Elective Course To Accommodate Budget Reductions
American Journal of Pharmaceutical Education. 75
2010
Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes.
Expert opinion on biological therapy. 10(5):801-6 [DOI] 10.1517/14712598.2010.481281. [PMID] 20367248.
2010
Saxagliptin (Onglyza) for Type 2 Diabetes Mellitus
. 81:1483-1484
2008
Angiotensin Ii Vaccine: a Novel Approach in the Treatment of Hypertension
Expert Opinion on Biological Therapy. 8:1669-1673 [DOI] 10.1517/14712590802442419.
2008
Dpp-Iv Inhibitors: a Review of Sitagliptin, Vildagliptin, Alogliptin, and Saxagliptin
Formulary. 43

Education

Pharm.D.
1999 · University of Florida

Teaching Profile

Courses Taught
2017-2021
PHA5788C Patient Care 6
2020
PHA5956 Special Topics/Self-Directed Study
2018-2021
PHA5784C Pt Care 4: GI and Renal
2019
PHA5733 Year 2 Enhancement
2019
PHA5734 Year 3 Enhancement
2017-2019,2021
PHA5787C Pt Care 5: Endo
2019
PHA5026C Personal and Professional Development VI
2018-2019
PHA5166L Prof Skills Lab Vi
2017-2018
PHA5165L Prof Skills Lab V
2014-2018
PHA5890 Women’S Hlth Pharm
2018,2020-2021
PHA5060 Ambulatory Care
2007,2009-2018,2018
PHA5788 Pharmacotherapy 6
2014-2015,2017
PHA5781 Patient Care I
2017
PHA5164L Prof Skills Lab Iv
2015-2016
PHA5560 Pathphys-Pt Assess I
2011-2013,2016
PHA5784 Pharmacotherapy 4
2013-2015
PHA5108L Pharmaceu Skls Lab 1
2015
PHA5101 Dosage Forms 2
2013-2014
PHA5933 Select Top Pharmacy
2011-2012,2014
PHA5239 Pharm Law and Ethics
2011-2014
PHA5782 Pharmacotherapy 2
2013
PHA5942C Intr Pha Prac Exp 2
2013
PHA5644 Adv Pharm Pract Exp 3
2010,2012-2013
PHA5783 Pharmacotherapy 3
2011
PHA5907 Research in Phar Prac
2021
PHA5787 Pharmacotherapy 5
2021
PHA5922 Thinking Skills

Contact Details

Phones:
Business:
(407) 313-7004
Emails:
Business:
estonge@ufl.edu